Co-Diagnostics Expands CoSara's South Asia Footprint, Targets USD 13 Billion Diagnostics Market
Co-Diagnostics, Inc. has announced a strategic expansion of its South Asia operations through its joint venture CoSara Diagnostics Pvt. Ltd., formed in partnership with Ambalal Sarabhai Enterprises Limited.
Biotechnology | 23/03/2026 | By Darshana | 105
From Generics to Biologics: Semaglutide Reshapes Pharma Manufacturing in India
The recent developments around semaglutide in India—triggered by patent expiry and rapid domestic entry—are poised to significantly reshape the country’s pharmaceutical manufacturing landscape.
Biotechnology | 23/03/2026 | By Darshana | 148
Belief Pharmaceuticals Group has announced that its gene therapy BM-H901 injection (generic name: Popedacoq injection) has received approval from the Macau Drug Administration for treating adult patients with moderate to severe haemophilia B (congenital factor IX deficiency).
Biotechnology | 22/03/2026 | By Darshana
GI Innovation, Johnson & Johnson Partner for Phase Ib Trial in Advanced Prostate Cancer
GI Innovation enters clinical supply agreement with Johnson & Johnson to evaluate GI-102 and pasritamig combination therapy in metastatic castration-resistant prostate cancer patients.
Biotechnology | 21/03/2026 | By News Bureau | 132
Zydus Lifesciences Launches Aerolife Mini, India's First Portable Foldable Spacer
Zydus introduces Aerolife Mini, a compact pMDI enhancer designed to improve inhaler drug delivery and patient compliance in respiratory care through a convenient, foldable design.
Biotechnology | 20/03/2026 | By News Bureau
Samsung Bioepis Partners with Sandoz for Next-Gen Biosimilar Candidates
Samsung Bioepis has partnered with Sandoz to develop and commercialise up to five biosimilar candidates, including SB36 (vedolizumab), across global markets, excluding select Asian regions, strengthening its pipeline in immunology and oncology.
Biotechnology | 19/03/2026 | By News Bureau
Aplagon Doses First Patient in Phase IIa Trial of APAC for Chronic Limb-Threatening Ischemia
Aplagon has dosed the first patient in its Phase IIa HEALING trial evaluating APAC therapy for Chronic Limb?Threatening Ischemia caused by Peripheral Arterial Occlusive Disease in Finland.
Biotechnology | 16/03/2026 | By News Bureau
WHO Unveils Three Product Profiles For Next-Generation Antibiotics
The World Health Organization has released three new Target Product Profiles (TPPs) aimed at guiding the development of antibacterial medicines to combat drug-resistant bacteria responsible for severe infections such as bloodstream infections, pneumonia, urinary tract infections and meningitis.
Biotechnology | 12/03/2026 | By Darshana | 213
National Institute for Health and Care Research announces first Tessa Jowell AHP Research Fellows to advance neuro-oncology research, addressing rehabilitation and supportive care gaps for brain tumour patients across the United Kingdom.
Biotechnology | 10/03/2026 | By News Bureau
PureHealth Research Launches Botanical GLP-1 Supplements to Support Natural Metabolic Health
PureHealth Research introduces a new range of plant-based GLP-1 supplements formulated with clinically studied botanicals to naturally support satiety signaling, metabolic wellness, and healthy blood sugar levels.
Biotechnology | 09/03/2026 | By News Bureau | 136
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy